https://www.thebodypro.com/category/pregnancy-childbirth-hiv
Providing Quality HIV Care

Pregnancy, Childbirth, and HIV

The Latest

Lynne Mofenson
Interviews

After Years of Decline, Perinatal HIV Transmission Has Hit a Plateau. Why?

This researcher has some ideas about what we need to do to address the problem.

By Terri Wilder, M.S.W.
vaginal ring
Conference Coverage

Contraceptives Don’t Increase HIV Risk, but They Do Interact With Some Antiretrovirals

A CROI 2020 roundup of studies on birth control and women living with HIV.

By Barbara Jungwirth
pregnant belly
Conference Coverage

Tempering Previous Concerns, Study Finds Dolutegravir Safest HIV Treatment During Pregnancy

New data shows the drug is not more likely to cause birth defects.

By Sony Salzman
pregnant woman and partner cuddling on couch
News

New Study Will Test Safety of PrEP and Dapivirine Ring in Pregnancy

While the vaginal ring is still currently under FDA review, the new study will show whether it is safe and acceptable for people who are pregnant.

By Martha Kempner
close up of cannabis plant
News

This Week in HIV Research: More Answers—and Questions—on Cannabis Use

Jan. 23, 2020: Neurocognitive benefits of cannabis use; how unquantifiable HIV in CSF correlates to executive function; updated findings on efavirenz and microcephaly; cost-efficacy of a specialized HIV care coordination team.

By Barbara Jungwirth and Myles Helfand
woman working in the medical lab
News

One-Two Punch of Antibodies and Antiretrovirals Stops HIV Infection in Primate Infants

While it is too soon to tell, this research involving broadly neutralizing antibodies could point to new methods for preventing vertical transmission.

By Sony Salzman
Dolutegravir and Pregnancy photo illo
Features

Tsepamo Study Provides Critical Update on Neural Tube Defects and Dolutegravir

A lot of pregnancies in Botswana were anxiously followed after results from the Tsepamo study were revealed in late 2018. Updated data provide a medium-sized sigh of relief.

By David Alain Wohl, M.D.
pregnant woman talking to doctor
Conference Coverage

Raltegravir Not Linked to Birth Defects, Study Shows

Amidst uncertainty regarding the safety of some integrase inhibitors during pregnancy, a study shows that an older integrase inhibitor may be a good option for those with HIV who intend to give birth.

By Kenyon Farrow
Hand holding syringe in backlight
News Analysis

Controversy Erupts Around Study on Contraception and HIV Risk

The ECHO trial faces backlash and criticism.

By Sony Salzman
pregnant stomach
News

This Week in HIV Research: Pregnancy Findings That Aren't About Dolutegravir

Aug. 1, 2019: Raltegravir OK in pregnancy; HIV disclosure and viral suppression among pregnant women; newborn size following HIV exposure; causes of hearing problems among people with HIV.

By Barbara Jungwirth and Myles Helfand